← Leaderboards
Robert C Gallo
University Of Md Biotechnology Institute
$3,122,170
Attributed
$3,122,170
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.7M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$24,544,666 · 8
By mechanism
P01$22,425,179 · 5
RC2$1,072,678 · 1
R13$1,046,809 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Md Biotechnology Institute
Same institution · by research overlap
- Steven Birken$887,264
- Joseph L Bryant$154,069
- John P Marino$1,941,633
Others in their field
Top investigators on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$642,073,624
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$513,687,120
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United States National Institutes Of HealthProgramsPublishingTravelCollaborationsInstitutesPublicationsEnsureResearch PersonnelAcquired Immunodeficiency SyndromeLinkVaccinesMeetingsEventFloorParticipantCommunitiesPoliciesInternationalLecturesFosteringKnowledge BaseAids/Hiv ProblemPosters
Grant awards (41)
Institute of Human Virology Annual Meeting 2016-2021$30,000
R13 · FY2021 · AI · contact PI
Durable Antibody Mediated Protection Against HIV$3,389,755
P01 · FY2019 · AI · contact PI
Admin-Core A$197,665
P01 · FY2019 · AI · contact PI
Institute of Human Virology Annual Meeting 2016-2021$30,000
R13 · FY2019 · AI · contact PI
Durable Antibody Mediated Protection Against HIV$3,373,790
P01 · FY2018 · AI · contact PI
Admin-Core A$221,868
P01 · FY2018 · AI · contact PI
Institute of Human Virology Annual Meeting 2016-2021$24,600
R13 · FY2018 · AI · contact PI
Durable Antibody Mediated Protection Against HIV$4,394,406
P01 · FY2017 · AI · contact PI
Admin-Core A$211,426
P01 · FY2017 · AI · contact PI
Institute of Human Virology Annual Meeting 2016-2021$103,200
R13 · FY2017 · AI · contact PI
Durable Antibody Mediated Protection Against HIV$3,215,425
P01 · FY2016 · AI · contact PI
Admin-Core A$217,655
P01 · FY2016 · AI · contact PI
Institute of Human Virology Annual Meeting 2016-2021$55,655
R13 · FY2016 · AI · contact PI
Institute of Human Virology Annual Meeting 2011-2016$75,355
R13 · FY2015 · AI · contact PI
Institute of Human Virology Annual Meeting 2011-2016$50,000
R13 · FY2014 · AI · contact PI
Institute of Human Virology Annual Meeting 2011-2016$45,000
R13 · FY2013 · AI · contact PI
Institute of Human Virology Annual Meeting 2011-2016$35,749
R13 · FY2012 · AI · contact PI
Institute of Human Virology Annual Meeting 2011-2016$53,999
R13 · FY2011 · AI · contact PI
FLSC Combined with Tat Toxoid as an HIV Prophylactic Vaccine$458,647
RC2 · FY2010 · CA · contact PI
FLSC Combined with Tat Toxoid as an HIV Prophylactic Vaccine$135,693
RC2 · FY2010 · CA · contact PI
Institute of Human Virology Annual Meeting 2005-2010$82,000
R13 · FY2010 · AI · contact PI
FLSC Combined with Tat Toxoid as an HIV Prophylactic Vaccine$478,338
RC2 · FY2009 · CA · contact PI
Institute of Human Virology Annual Meeting 2005-2010$1
R13 · FY2009 · AI · contact PI
Institute of Human Virology Annual Meeting 2005-2010$68,000
R13 · FY2008 · AI · contact PI
Institute of Human Virology Annual Meeting 2005-2010$1
R13 · FY2007 · AI · contact PI
Institute of Human Virology Annual Meeting 2005-2010$45,999
R13 · FY2006 · AI · contact PI
Institute of Human Virology Annual Meeting 2005-2010$80,500
R13 · FY2005 · AI
Institute of Human Virology Annual Meeting 2004$96,500
R13 · FY2004 · AI
Polypeptide Microbicides Targeting CCR5$1,368,411
P01 · FY2003 · AI
Institute of Human Virology Annual Meeting 2003$38,500
R13 · FY2003 · AI
Polypeptide Microbicides Targeting CCR5$1,368,828
P01 · FY2002 · AI
KAPOSI'S SARCOMA: PATHOGENESIS AND NOVEL THERAPY$742,500
P01 · FY2002 · CA
Institute of Human Virology Annual Meeting 2002-2004$61,750
R13 · FY2002 · AI
MECHANISMS OF ACTION OF HAF--KAPOSI'S SARCOMA$0
P01 · FY2002 · CA
KAPOSI'S SARCOMA: PATHOGENESIS AND NOVEL THERAPY$1,440,823
P01 · FY2001 · CA
Polypeptide Microbicides Targeting CCR5$742,323
P01 · FY2001 · AI
ANNUAL MEETING OF THE INSTITUTE OF HUMAN VIROLOGY$50,000
R13 · FY2001 · AI
MECHANISMS OF ACTION OF HAF--KAPOSI'S SARCOMA$0
P01 · FY2001 · CA
KAPOSI'S SARCOMA: PATHOGENESIS AND NOVEL THERAPY$1,386,235
P01 · FY2000 · CA
MECHANISMS OF ACTION OF HAF--KAPOSI'S SARCOMA$154,069
P01 · FY2000 · CA
ANNUAL MEETING OF THE INSTITUTE OF HUMAN VIROLOGY$20,000
R13 · FY2000 · AI